Accelerated midlife epigenetic age associates with poor later life brain health in the 1946 British Birth Cohort.

James Groves, Jane Maddock, Ashvini Keshavan, William Coath, Jennifer M Nicholas, Aaron Z Wagen, David M Cash, Frederik Barkhof, Marcus Richards, James H. Cole, Jonathan M Schott

Dementia Research Centre, UCL Queen Square Institute of Neurology, London, London, United KingdomDementia Research Centre, UCL Queen Square Institute of Neurology, London, London, United Kingdom · pubmed

Paper

Abstract

Accelerated epigenetic ageing has been associated with various age‐related health outcomes, but its relevance for dementia risk prediction is unclear. We investigated whether accelerated midlife epigenetic age associates with poor later‐life brain health.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper investigates the association between accelerated midlife epigenetic age and later-life brain health, which touches on the biological mechanisms of aging. However, it primarily focuses on correlational findings rather than addressing root causes of aging or proposing interventions for lifespan extension. Thus, while it contributes to the understanding of aging-related health outcomes, its impact is limited and more incremental than transformative.

Author of this paper? Send a correction.